BioSight
Companies
Neumora Therapeutics, Inc. logo

NMRA

NASDAQWATERTOWN, MA
Neumora Therapeutics, Inc.

Neumora Therapeutics develops drug candidates using a precision neuroscience approach aimed at improving the success rate of drug discovery and development compared to traditional methods. Based on the forward-looking statements in their filing, the company is focused on advancing product candidates through clinical trials, though the specific therapeutic areas and current development stage are not detailed in this excerpt. The filing indicates Neumora is in active research and development phases with multiple ongoing or planned preclinical studies and clinical trials.

Price history not yet available for NMRA.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar